Patent Yard Sign in
Canadian application, no grantCanada

Pharmaceutical compositions and methods for treating anxiety, anxiety disorders and memory impairment using naaladase inhibitors

CA 2378467 A1 · Owner: Slusher, Barbara S. · Inventors: Slusher, Barbara S.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention relates to pharmaceutical compositions and methods of using NAALADase inhibitors for treating glutamate-mediated diseases disorders , and conditions selected from the group consisting of anxiety anxiety , disorders and memory impairment.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed June 30, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 30, 2020.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 30, 2022.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJune 30, 2000
GrantedNo grant recorded
Term endedJune 30, 2020
Patent numberCA 2378467 A1
Classification (IPC)A61K31/00 +2 more

Timeline

Timeline From CIPO dates

2001200320052007200920112013201520172019Application filedJune 30, 2000Term endedJune 30, 2020

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.